U.S., Aug. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07763418) titled 'A Study to Evaluate the Pharmacokinetics and Safety of Golcadomide in Participants With Severe Renal Impairment and End-Stage Renal Disease Compared With Participants With Normal Renal Function' on Aug. 10.
Brief Summary: The purpose of this study is to assess the pharmacokinetics and safety of golcadomide (BMS-986369) in matched healthy participants with normal renal function, adult participants with severe renal impairment, and participants with end-stage renal disease.
Study Start Date: Aug. 24
Study Type: INTERVENTIONAL
Condition:
Kidney Failure, Chronic
Intervention:
DRUG: Golcadomide
Specified dose on specified days
Re...